scholarly journals Medication Errors: Reported Prescription Faults and Prescription Error

2021 ◽  
Vol 12 (2) ◽  
pp. 1672-1678
Author(s):  
Ali Alshahrani ◽  
Mona Alsheikh ◽  
Mohammad Yusuf

The present study aimed to evaluate the trends of prescription  errors that did not caused any harm to the patients and the prescription errors that were identified before reaching to the patients in the year 2017 at a tertiary care hospital in Kingdom Saudi Arabia. Simple random sampling and sampling based on prescription errors that were identified, documented, and reported before reaching the patients in the first three quarters of 2017 were performed in present observational retrospective study. Descriptive analysis with D’Agostino & Pearson omnibus were applied for normality testing at 95% CI through one-sample t-test to compare the prescription errors that did not cause harm to the patients and were identified before reaching the patient in the first quarter (Q1), the second quarter (Q2), and the third quarter (Q3) of 2017. Total number of prescription errors that did not caused harm to the patients were 1,601 in Quarter 1 further decreased to 1,422 in Quarter 2 and then increased to 1,710 in Quarter 3 of 2017. Furthermore, the total number of prescription errors that did not cause harm to the patients were 1,601 in Quarter 1 further decreased to 1,422 in Quarter 2 and then increased to 1,710 in Quarter 3 of 2017. The current study revealed that prescription errors were common in the tertiary Hospital, Taif, Saudi Arabia. Therefore, educating the prescribers to reduce prescription errors through seminars, conferences, and workshops is essential. Also, a joint training exercise for the pharmacist and doctors would minimize the prescribing errors.

2020 ◽  
Vol 12 (4) ◽  
pp. 343-347
Author(s):  
Abedulla Khan Kayamkani ◽  
Turki Khalid Abdullkader Bayazeed ◽  
Mohammed Salah M Aljuhani ◽  
Sami Majed Sami Koshak ◽  
Aejaz Abdullatif Khan ◽  
...  

Vacunas ◽  
2020 ◽  
Vol 21 (2) ◽  
pp. 95-104 ◽  
Author(s):  
Y.M. AlGoraini ◽  
N.N. AlDujayn ◽  
M.A. AlRasheed ◽  
Y.E. Bashawri ◽  
S.S. Alsubaie ◽  
...  

2019 ◽  
Vol 12 (5) ◽  
pp. 666-672 ◽  
Author(s):  
Abdulrahman Al-Matary ◽  
Humariya Heena ◽  
Ayah S. AlSarheed ◽  
Wafa Ouda ◽  
Dayel A. AlShahrani ◽  
...  

2014 ◽  
Vol 9 (1) ◽  
pp. 24039 ◽  
Author(s):  
Krishnappa Lakshmana Gowda ◽  
Mohammed A. M. Marie ◽  
Yazeed A Al-Sheikh ◽  
James John ◽  
Sangeetha Gopalkrishnan ◽  
...  

Author(s):  
Harsha Sreedharan ◽  
KB Asha Pai

Introduction: Methicillin-Resistant Staphylococcus aureus(MRSA) infection is a major global healthcare problem, the prevalence of which varies from 25-50% in India. It is known to cause Skin and Soft tissue Infections (SSI), endovascular infections, endocarditis, pneumonia, septic arthritis, osteomyelitis, and sepsis. Vancomycin is the drug of choice for treating severe MRSA infections. Ceftaroline, a fifth-generation cephalosporin has been approved by the United States Food and Drug Administration (US FDA) for treating acute bacterial SSI caused by susceptible micro-organisms including MRSA, Community acquired respiratory tract infection, MRSA bacteremia and endocarditis. Aim: To assess the susceptibility of clinical isolates of S. aureusto ceftaroline, in a Tertiary Care Hospital. Materials and Methods: This prospective study was conducted in the Department of Microbiology of a Tertiary Care Hospital over a period of two months from June 2019 to July 2019. S.aureus isolates from various clinical samples were screened for methicillin resistance by disc diffusion method using cefoxitin disc and ceftaroline susceptibility of these isolates was assessed by E-strip method. The isolates were classified as ceftaroline susceptible, Susceptibility Dose Dependent (SDD) and ceftaroline resistant respectively as per CLSI guidelines. A descriptive analysis of the data was done and the results were presented as frequencies and percentages. Results: All the S.aureus isolates were found to be susceptible to ceftaroline. Methicillin Sensitive Staphylococcus aureus(MSSA) isolates had lower Minimum Inhibitory Concentration (MIC) when compared to MRSA. The highest MIC among MRSA was 0.5 μg/mL. Conclusion: Ceftaroline can be considered as an effective alternative for treatment of infections caused by MRSA.


Cureus ◽  
2020 ◽  
Author(s):  
Mohammed S Alharbi ◽  
Bander K Alanazi ◽  
Ibrahim A Alquhays ◽  
Nawaf A Alhamied ◽  
Abdullah Al Shimemeri

Sign in / Sign up

Export Citation Format

Share Document